LAURUSLABS — Laurus Labs Balance Sheet
0.000.00%
- IN₹556.75bn
- IN₹579.45bn
- IN₹55.54bn
- 97
- 4
- 100
- 79
Annual balance sheet for Laurus Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 485 | 754 | 457 | 1,389 | 995 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13,457 | 13,950 | 17,047 | 18,187 | 22,201 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 30,749 | 33,446 | 34,617 | 38,350 | 43,323 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 22,772 | 32,086 | 37,002 | 40,475 | 43,160 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 57,507 | 69,680 | 76,604 | 83,870 | 93,356 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 24,572 | 26,810 | 24,323 | 31,123 | 35,397 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 31,531 | 36,169 | 36,229 | 42,761 | 48,630 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 25,976 | 33,512 | 40,375 | 41,110 | 44,726 |
| Total Liabilities & Shareholders' Equity | 57,507 | 69,680 | 76,604 | 83,870 | 93,356 |
| Total Common Shares Outstanding |